Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – medRxiv News release: RECOVERY trial finds no benefit from azithromycin in patients hospitalised with COVID-19 Commentary: Expert reaction to preprint from the RECOVERY trial on the antibiotic azithromycin in patients hospitalised with COVID-19, reporting no benefit – Science Media Centre […]
The post [Preprint] RECOVERY trial: Azithromycin does not improve outcomes in hospitalized patients with COVID-19 appeared first on Links Medicus.
Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.